Zhende Medical Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Zhende Medical Co., Ltd. carries a market capitalization of 23.67B, placing it among publicly traded companies globally. Its enterprise value stands at 5.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.67B |
| Enterprise Value | 5.95B |
Share Statistics
Zhende Medical Co., Ltd. currently has 266.45M shares outstanding.
| Shares Outstanding | 266.45M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Zhende Medical Co., Ltd. trades at a trailing price-to-earnings ratio of 16.18. The price-to-sales ratio is 1.32, and the price-to-book ratio stands at 1.58.
| PE Ratio | 16.18 |
| PS Ratio | 1.32 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 7.36 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Zhende Medical Co., Ltd. trades at an EV/EBITDA multiple of 15.10 and an EV/FCF ratio of 7.48. The EV/Sales ratio of 1.38 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.10 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.38 |
| EV / EBITDA | 15.10 |
| EV / EBIT | 15.10 |
| EV / FCF | 7.48 |
Financial Position
Zhende Medical Co., Ltd. maintains a current ratio of 1.77, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.11, indicating elevated leverage, while an interest coverage ratio of 15.40 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.77 |
| Quick Ratio | 0.79 |
| Debt / Equity | 24.11 |
| Debt / EBITDA | 3.62 |
| Interest Coverage | 15.40 |
Financial Efficiency
Zhende Medical Co., Ltd. posts a return on equity of 10.00 and a return on invested capital of 4.66.
| Return on Equity (ROE) | 10.00 |
| Return on Assets (ROA) | 4.35 |
| Return on Invested Capital (ROIC) | 4.66 |
| Return on Capital Employed (ROCE) | 7.31 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.73 |
Taxes
Over the trailing twelve months, Zhende Medical Co., Ltd. has paid 74.12M in income taxes, reflecting an effective tax rate of 17.05.
| Income Tax | 74.12M |
| Effective Tax Rate | 17.05 |
Stock Price Statistics
Zhende Medical Co., Ltd.'s stock has gained approximately 328.87189% over the past 52 weeks. The 50-day moving average sits at 88.28, while the 200-day moving average is 80.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 328.87189% |
| 50-Day Moving Average | 88.28 |
| 200-Day Moving Average | 80.85 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zhende Medical Co., Ltd. generated 4.32B in revenue and converted that into 351.83M in net income, yielding earnings per share of 1.34. EBITDA reached 393.71M, while operating income came in at 393.71M.
| Revenue | 4.32B |
| Gross Profit | 1.45B |
| Operating Income | 393.71M |
| Pretax Income | 434.69M |
| Net Income | 351.83M |
| EBITDA | 393.71M |
| EBIT | 393.71M |
| Earnings Per Share (EPS) | 1.34 |
Balance Sheet
Zhende Medical Co., Ltd. holds 1.45B in cash and equivalents against 1.42B in total debt, resulting in a net debt position of 496.08M. Total book value stands at 3.60B, with working capital of 1.42B providing operational flexibility.
| Cash & Cash Equivalents | 1.45B |
| Total Debt | 1.42B |
| Net Debt | 496.08M |
| Equity (Book Value) | 3.60B |
| Book Value Per Share | 13.34 |
| Working Capital | 1.42B |
Cash Flow
After subtracting -773.70M in capital expenditures, free cash flow totaled -773.70M - equivalent to -2.87 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -773.70M |
| Free Cash Flow | -773.70M |
| FCF Per Share | -2.87 |
Margins
Zhende Medical Co., Ltd. operates with a gross margin of 33.44, reflecting its pricing power and cost economics. The operating margin of 9.11 and net profit margin of 8.14 provide insight into operational efficiency.
| Gross Margin | 33.44 |
| Operating Margin | 9.11 |
| Pretax Margin | 10.06 |
| Profit Margin | 8.14 |
| EBITDA Margin | 9.11 |
Dividends & Yields
The company's payout ratio of 88.73 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.22 |
| Dividend Yield | N/A |
| Payout Ratio | 88.73 |
| Shareholder Yield | -2.31 |
| FCF Yield | 13.59 |
Stock Splits
Zhende Medical Co., Ltd.'s most recent stock split took place on June 8, 2020 with a 5:7 split ratio.
| Last Split Date | 6/8/2020 |
| Split Ratio | 5:7 |
Scores
Zhende Medical Co., Ltd. posts an Altman Z-Score of 3.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.13 |